Showing 1531-1540 of 1735 results for "".
- FDA Wins Case Against Florida Stem Cell Clinic that Harmed three Women’s Visionhttps://modernod.com/news/fda-wins-case-against-florida-stem-cell-clinic-that-harmed-three-womens-vision/2476631/The FDA has won a federal judge’s backing for its efforts to crack down on the rapidly growing stem cell industry that promises all kinds of unproven treatments for serious diseases, according to an NBC News
- Schwind Introduces WiseNET Intelligent Web-Based Databasehttps://modernod.com/news/schwind-introduces-wisenet-intelligent-web-based-database/2476554/Schwind WiseNET is a web-based database that allows the user to capture and evaluate refractive treatment data quickly and precisely, and present it graphically for all sorts of uses in daily clinical work. Diagrams s
- Nicox Signs Agreement for Zerviate in China for Up to €17 Million in Milestone Payments Plus Royaltieshttps://modernod.com/news/nicox-signs-agreement-for-zerviate-in-china-for-up-to-e17-million-in-milestone-payments-plus-royalties/2476381/Nicox SA and Ocumension Therapeutics announced they have entered into an exclusive license agreement for the development and commercialization of Nicox’s product Zerviate (cetirizine ophthalmic solution), 0.24% for the treatment of all
- College of Optometrists in Vision Development & NORA Issue Joint Recommendation for Optometric Evaluation Following Brain Injuryhttps://modernod.com/news/college-of-optometrists-in-vision-development-nora-issue-joint-recommendation-for-optometric-evaluation-following-brain-injury/2476285/The College of Optometrists in Vision Development (COVD) and the Neuro Optometric Rehabilitation Association (NORA) issued a joint call-to-action to all healthcare professionals to consider the need for medical and/or functional optometric rehabilitation services for patients who have suffered a
- USPSTF Reaffirms Advice on Prevention of Gonococcal Eye Infections in Newbornshttps://modernod.com/news/uspstf-reaffirms-advice-on-prevention-of-gonococcal-eye-infections-in-newborns/2476334/The U.S. Preventive Services Task Force (USPSTF) continues to recommend that all newborns be treated with a topical antibiotic ointment to prevent gonococcal eye infections, according to a Reuters report. This “A” recom
- Dry Eye Symptom Screens Show Modest Accuracyhttps://modernod.com/news/dry-eye-symptom-screens-show-modest-accuracy/2479636/In head-to-head comparisons, two of five dry eye screens showed a statistically significant ability to detect signs of the disorder, but all demonstrated relatively modest diagnostic accuracy, researchers say, according to a Reuters report
- T-Cell Immune Responses Drive Neurodegeneration in Glaucomahttps://modernod.com/news/t-cell-immune-responses-drive-neurodegeneration-in-glaucoma/2479933/T-cell immune responses are partly responsible for progressive neurodegeneration in glaucoma, researchers report. “Current treatment of glaucoma is almost all focused on reducing intraocular pressure (IOP) and amelioration of
- FCI Ophthalmics Announces Availability of EzyPor Polyethylene Orbital Implanthttps://modernod.com/news/fci-ophthalmics-announces-availability-of-ezypor-polyethylene-orbital-implant/2481336/FCI Ophthalmics announced the launch of EzyPor in the United States. EzyPor is a high density polyethylene orbital implant with a patented suturing platform, indicated for enucleation, evisceration, and secondary implantation. Ezyor is designed to have a smooth
- FCI Ophthalmics Announces FDA Clearance of Oculid Implantable and External Eyelid Weights for the Treatment of Lagophthalmoshttps://modernod.com/news/fci-ophthalmics-announces-fda-clearance-of-oculid-implantable-and-external-eyelid-weights-for-the-treatment-of-lagophthalmos/2480641/FCI Ophthalmics announced <
- FCI Ophthalmics Announces Availability of LacriJet for Monocanalicular Nasolacrimal Intubationhttps://modernod.com/news/fci-ophthalmics-announces-availability-of-lacrijet-for-monocanalicular-nasolacrimal-intubation/2478907/FCI Ophthalmics announced the launch of the LacriJet in the United States. It is the first, self-retaining monocanalicular nasolacrimal intubation preloaded on a single use injector, according to FCI Ophthalmics. LacriJet consists of a single use injector handpiece into which a silicone tu